With over 200 cases filed against Janssen Pharmaceuticals concerning vision-related problems linked to Elmiron, plaintiffs are seeing new developments towards trial, possibly in 2023. Plaintiffs allege long-term use of the bladder-pain drug caused vision impairment symptoms, and for many, a degenerative eye disorder called “pigmentary maculopathy.” The cases were consolidated into a multi-district litigation in New Jersey, where lawyers for both plaintiffs and defendants are preparing a select few cases for trial in January 2023.
Is it Too Late to File an Elmiron Lawsuit? Call for a Free Consultation.
Cases are still being filed in the Elmiron MDL. Our experienced attorneys are investigating vision loss claims associated with the drug. Contact us by submitting the form or by calling us at (866) 575-7435 for a confidential evaluation of your potential claim.